Hair, tattoos, scars, and cosmetics as optical confounders – Insurance companies brief

Decision-ready map

• RPM risk: confounders drive false alerts, missed events, and member churn

• Contract: require interference evidence, labeling, and device transparency

• Protocol: symptom-first escalation + relocation steps + confirmatory pathways

• Audit: track “unable-to-measure” and escalations by member subgroup/context

• Governance: revalidate after device/app updates; monitor complaint signals

(1) What it is

For payers, surface confounders are program risk: confounder-driven false alerts increase utilization and member churn, while confounder-driven false reassurance can delay escalation. Theme 6 translates into contracting requirements (interference evidence and labeling), protocol design (relocation + quality gating), and audits (track failure rates and complaints).

(2) Who it helps

Medical directors, RPM program leads, contracting teams, and quality/equity leaders reimbursing or deploying optical monitoring devices.

(3) What evidence exists

Evidence shows nail polish and dyes can distort oximetry; scars, tattoos and cosmetics alter optical baselines; standards exist for pulse oximeter performance. These create foreseeable program failure modes that can be mitigated through vendor requirements and protocols.

(4) Translation barriers

Commodity device procurement without transparency; pooled outcome reporting; rigid threshold scripts; lack of tracking for ‘unable-to-measure’ and confounder-related complaints; updates change device/app behavior without revalidation.

(5) Equity/safety checks

Ensure programs don’t exclude members with tattoos/cosmetics/scars; offer alternatives and non-stigmatizing instructions; audit failure rates for disparate impact where lawful.

(6) Decision questions

• Do vendor contracts require interference evidence, labeling, and device/app version transparency?

• Do protocols include relocation steps and symptom-first escalation?

• Are failure rates (‘unable-to-measure’) tracked and acted on?

• Are complaint signals monitored for confounder patterns?

• Is revalidation required after device/app updates?

(7) Practical next steps

1) Require interference matrix evidence and labeling in contracts.

2) Standardize protocols: inspect/relocate/quality gate + confirmatory pathways.

3) Build dashboards: false alerts, unable-to-measure, complaints, escalations.

4) Tie vendor accountability to maintaining performance after updates.

5) Communicate member instructions clearly with alternatives and mismatch guidance.

(8) References

Aggarwal AN, Agarwal R, Dhooria S, et al. Impact of Fingernail Polish on Pulse Oximetry Measurements: A Systematic Review. Respiratory Care. 2023.

https://doi.org/10.4187/respcare.10399

Yeganehkhah M, Dadkhahtehrani T, Bagheri AR, Kachoie A. Effect of Glittered Nail Polish on Pulse Oximetry Measurements in Healthy Subjects. Iran J Nurs Midwifery Res. 2019.

https://doi.org/10.4103/ijnmr.IJNMR_176_17

Hueter L, Schwarzkopf K, Karzai W. Interference of patent blue V dye with pulse oximetry and co-oximetry. Eur J Anaesthesiol. 2005.

https://doi.org/10.1017/S0265021505230818

Howard JD, Moo V, Sivalingam P. Anaphylaxis and other adverse reactions to blue dyes: a case series. Anaesth Intensive Care. 2011.

https://doi.org/10.1177/0310057X1103900221

Piñero A, Illana J, García-Palenciano C, et al. Effect on Oximetry of Dyes Used for Sentinel Lymph Node Biopsy. Arch Surg. 2004.

https://doi.org/10.1001/archsurg.139.11.1204

Poon KWC, Dadour IR, McKinley AJ. In situ chemical analysis of modern organic tattooing inks by micro-Raman spectroscopy. J Raman Spectrosc. 2008.

https://doi.org/10.1002/jrs.1973

Sadura F, Wróbel MS, Karpienko K. Colored Tattoo Ink Screening Method with Optical Tissue Phantoms and Raman Spectroscopy. Materials (Basel). 2021.

https://doi.org/10.3390/ma14123147

Tseng S-H, Hsu C-K, Lee JY-Y, et al. Noninvasive evaluation of collagen and hemoglobin in keloid scars using DRS. J Biomed Opt. 2012.

https://doi.org/10.1117/1.JBO.17.7.077005

Hsu C-K, Tzeng S-Y, Yang C-C, et al. Non-invasive evaluation of therapeutic response in keloid scar using diffuse reflectance spectroscopy. Biomed Opt Express. 2015.

https://doi.org/10.1364/BOE.6.000390

Yoshida K, Okiyama N. Estimation of reflectance/transmittance/absorbance of cosmetic foundation layer on skin. Opt Express. 2021.

https://doi.org/10.1364/oe.442219

Mancuso A, d’Avanzo ND, Cristiano MC, Paolino D. Reflectance spectroscopy to explore skin reactions to topical products. Front Chem. 2024.

https://doi.org/10.3389/fchem.2024.1422616

Kim KB, Baek HJ. Photoplethysmography in Wearable Devices: A Comprehensive Review. Electronics. 2023.

https://doi.org/10.3390/electronics12132923

Cooksey CC, Allen DW, Tsai BK. Reference Data Set of Human Skin Reflectance. J Res Natl Inst Stan. 2017.

https://doi.org/10.6028/jres.122.026

Cooksey CC, Allen DW, Tsai BK. Reference Data Set of Human Skin Reflectance (data). NIST. 2017.

https://doi.org/10.18434/M38597

IEC. ISO 80601-2-61:2026 Pulse oximeter equipment — safety and essential performance.

https://webstore.iec.ch/en/publication/74527